Company Kawasumi Laboratories, Incorporated
Stocks
7703
JP3225800006
Medical Equipment, Supplies & Distribution
Business description: Kawasumi Laboratories, Incorporated

Sales by Activity: Kawasumi Laboratories, Incorporated
| Fiscal Period: March | 2019 (JPY) | 2020 (JPY) |
|---|---|---|
Extracorporeal Circulation Relation | 12.71B | 11.2B |
Related to Blood and Blood Vessel | 11.4B | 11.12B |
Geographical breakdown of sales: Kawasumi Laboratories, Incorporated
| Fiscal Period: March | 2019 (JPY) | 2020 (JPY) |
|---|---|---|
Japan | 16.16B | 15.25B |
Asia Oceania | 3.87B | 2.99B |
United States | 2.86B | 2.92B |
Europe | 1.07B | 1B |
Others | 136M | 156M |
Executive Committee: Kawasumi Laboratories, Incorporated
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 2021-09-30 | |
Takeshi Saino
CEO | Chief Executive Officer | 64 | - |
Shigeharu Ochiai
AUD | Comptroller/Controller/Auditor | - | - |
Composition of the Board of Directors: Kawasumi Laboratories, Incorporated
| Director | Title | Age | Since |
|---|---|---|---|
Takeshi Saino
BRD | Director/Board Member | 64 | 2014-05-31 |
| Chairman | 63 | 2021-09-30 | |
Akinori Kanaoka
BRD | Director/Board Member | - | - |
Yoichi Sakata
BRD | Director/Board Member | - | - |
Akiko Okubo
BRD | Director/Board Member | - | - |
Tomomi Suwa
BRD | Director/Board Member | - | - |
Company details: Kawasumi Laboratories, Incorporated

Other Medical Equipment, Supplies & Distribution
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.13% | -1.09% | -23.81% | +0.48% | 177B | ||
| +0.18% | +1.26% | -1.91% | +13.45% | 118B | ||
| -2.85% | -3.60% | +7.03% | +73.54% | 60.78B | ||
| -0.26% | +2.81% | -3.30% | -31.23% | 49.53B | ||
| -0.44% | -0.62% | +7.00% | +40.11% | 48.29B | ||
| +0.68% | +4.05% | +15.03% | -8.74% | 32.96B | ||
| -2.64% | -0.83% | - | - | 28.94B | ||
| +1.27% | +6.49% | +42.85% | -7.00% | 25.48B | ||
| +1.13% | +5.26% | +10.51% | -22.76% | 21.77B | ||
| Average | -0.34% | +1.31% | +6.67% | +7.23% | 62.59B | |
| Weighted average by Cap. | -0.37% | +0.21% | -3.79% | +10.44% |

















